8-Carboxamidocyclazocine
A chemical compound related to cyclazocine
Chemical Compound | |
---|---|
Identifiers | |
CAS Number | |
PubChem CID | |
ChemSpider ID | |
UNII | |
ChEBI | |
ChEMBL | |
Properties | |
Chemical Formula | |
Molar Mass | |
Appearance | |
Density | |
Melting Point | |
Boiling Point | |
Hazards | |
GHS Pictograms | [[File:|50px]] |
GHS Signal Word | |
GHS Hazard Statements | |
NFPA 704 | [[File:|50px]] |
References | |
8-Carboxamidocyclazocine is a chemical compound that belongs to the class of benzomorphan opioids. It is structurally related to cyclazocine, a well-known opioid receptor agonist and antagonist.
Chemical structure and properties[edit | edit source]
8-Carboxamidocyclazocine is a derivative of cyclazocine, characterized by the presence of a carboxamide group at the 8-position of the benzomorphan skeleton. This modification alters its binding affinity and activity at various opioid receptors.
Pharmacology[edit | edit source]
8-Carboxamidocyclazocine acts as a kappa-opioid receptor agonist and a mu-opioid receptor partial agonist. The kappa-opioid receptor activity is associated with its potential analgesic effects, as well as its ability to produce dysphoria and hallucinations in some cases. The mu-opioid receptor activity contributes to its analgesic properties but also limits its use due to potential for abuse and dependence.
Potential therapeutic uses[edit | edit source]
Research into 8-Carboxamidocyclazocine has focused on its potential as an analgesic with reduced abuse potential compared to traditional mu-opioid receptor agonists. Its kappa-opioid receptor activity may also make it useful in treating conditions such as depression and anxiety, although these applications are still under investigation.
Side effects and safety[edit | edit source]
As with other kappa-opioid receptor agonists, 8-Carboxamidocyclazocine may cause side effects such as dysphoria, hallucinations, and sedation. Its safety profile is not fully established, and further research is needed to determine its long-term effects and potential for abuse.
Related pages[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD